Stock analysis searches answered, part 9 of 43

Innsuites hospitality trust bullish and bearish analyst opinions

This section ties “Innsuites hospitality trust bullish and bearish analyst opinions” to INNSUITES HOSPITALITY TRUST (ticker IHT), SEC Central Index Key 82473, an EDGAR registrant classified as “Real Estate Investment Trusts” and organised in OH, formerly known as REALTY REFUND TRUST. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-22. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-05-19 by INNSUITES HOSPITALITY TRUST (CIK 82473) — source document:

TO OUR BUSINESS InnSuites Hospitality Trust (the “ Trust ”) is headquartered in Phoenix, Arizona and is an unincorporated Ohio real estate investment trust formed on June 21, 1971. The Trust is not taxed as a real estate investment trust for federal taxation purposes but is taxed as a C-corporation. The Trust, with its affiliate RRF Limited Liability Limited Partnership (RRF LLLP), a Delaware limited liability limited partnership (the “ Partnership ”), owns interests in two hotels, operates and provides management services, and provides trademark license services, for two hotels. The Trust also holds a diversification investment in an efficient clean energy electricity generator innovation, as well as manages and holds an option to purchase, at cost, an independent boutique hotel reservation and independent hotel services investment.

Financial trend for INNSUITES HOSPITALITY TRUST from annual reports, periods 2023-01-31 to 2026-01-31: revenue went from $7.10 million (2023-01-31) to $7.60 million (2025-01-31), a change of +7.0%; net income (loss) went from $523,171 (2023-01-31) to -$1.43 million (2026-01-31), a change of -372.6%; total assets went from $17.02 million (2023-01-31) to $13.98 million (2026-01-31), a change of -17.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 82473, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures INNSUITES HOSPITALITY TRUST did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on INNSUITES HOSPITALITY TRUST (CIK 82473) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2017-06-22, and the most recent 10-K annual report was filed 2026-05-19. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 132 8-K or 6-K reports in INNSUITES HOSPITALITY TRUST’s recent EDGAR index, the 4 listed here run from 2026-07-10 to 2026-09-15, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 82473 is on the EDGAR company page; the latest 10-K/A there is dated 2026-06-18 and the oldest filing in the recent index dates from 1995-04-07. Insider trades for INNSUITES HOSPITALITY TRUST appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Inseego corp. bullish and bearish analyst opinions

This section ties “Inseego corp. bullish and bearish analyst opinions” to INSEEGO CORP. (ticker INSG), SEC Central Index Key 1022652, an EDGAR registrant classified as “Communications Equipment, NEC” and organised in an unstated jurisdiction, formerly known as NOVATEL WIRELESS INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-10-21. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-20 by INSEEGO CORP. (CIK 1022652) — source document:

Inseego is a leader in the design and development of cloud-managed wireless wide area network (“WAN”) and intelligent edge solutions. Our 5G WAN portfolio is comprised of secure and high-performance mobile broadband and fixed wireless access (“FWA”) solutions with associated cloud solutions for real time WAN visibility, monitoring, automation and control with centralized orchestration of network functions. These devices are specifically built for the carrier, enterprise and small and medium business (“SMB”) market segments with a focus on performance, scalability, quality and enterprise grade security. We also provide a Communication Service Provider (“CSP”) subscriber lifecycle management SaaS solution for carriers’ management of their government and complex enterprise customer subscriptions. Our 5G products and associated cloud solutions are designed in the U.S. and are used in networks where internet reliability and security is of the utmost importance.

Financial trend for INSEEGO CORP. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$67.97 million (2022-12-31) to $838,000 (2025-12-31), a change of +101.2%; total assets went from $159.95 million (2022-12-31) to $93.81 million (2025-12-31), a change of -41.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1022652, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures INSEEGO CORP. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on INSEEGO CORP. (CIK 1022652) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-05, and the most recent 10-K annual report was filed 2026-02-20. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 195 8-K or 6-K reports in INSEEGO CORP.’s recent EDGAR index, the 4 listed here run from 2026-06-22 to 2026-10-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1022652 is on the EDGAR company page; the latest 10-K there is dated 2026-02-20 and the oldest filing in the recent index dates from 2010-11-10. Insider trades for INSEEGO CORP. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Intellinetics, inc. bullish and bearish analyst opinions

This section ties “Intellinetics, inc. bullish and bearish analyst opinions” to INTELLINETICS, INC. (ticker INLX), SEC Central Index Key 1081745, an EDGAR registrant classified as “Services-Prepackaged Software” and organised in NV, formerly known as GLOBALWISE INVESTMENTS INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-07. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-30 by INTELLINETICS, INC. (CIK 1081745) — source document:

Intellinetics is a Nevada holding company incorporated in 1997, with two wholly-owned subsidiaries: (i) Intellinetics Ohio and (ii) Graphic Sciences. Intellinetics Ohio was incorporated in 1996, and on February 10, 2012, Intellinetics Ohio became the sole operating subsidiary of Intellinetics as a result of a reverse merger and recapitalization. On March 2, 2020, Intellinetics purchased Graphic Sciences, Inc. We are a document services and software solutions company serving both the small-to-medium business and governmental sectors with their digital transformation and process automation initiatives. Our digital transformation products and services are provided through two reporting segments: Software and Document Services. Our Software segment, previously referred to as Document Management, consists primarily of solutions involving our software platform, allowing customers to capture and manage their documents across operations such as scanned hard-copy documents and digital documents including those from Microsoft Office 365, digital images, audio, video and emails.

Financial trend for INTELLINETICS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $24,027 (2022-12-31) to -$1.87 million (2025-12-31), a change of -7895.0%; total assets went from $19.94 million (2022-12-31) to $17.31 million (2025-12-31), a change of -13.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1081745, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures INTELLINETICS, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on INTELLINETICS, INC. (CIK 1081745) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-12, and the most recent 10-K annual report was filed 2026-03-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 179 8-K or 6-K reports in INTELLINETICS, INC.’s recent EDGAR index, the 4 listed here run from 2026-05-14 to 2026-09-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1081745 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2000-10-02. Insider trades for INTELLINETICS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ioneer ltd bullish and bearish analyst opinions

This section ties “Ioneer ltd bullish and bearish analyst opinions” to ioneer Ltd (ticker IONR, GSCCF), SEC Central Index Key 1896084, an EDGAR registrant classified as “Mining & Quarrying of Nonmetallic Minerals (No Fuels)” and organised in Australia. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-08-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-29 by ioneer Ltd (CIK 1896084) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 46 A. Operating Results 46 B. Liquidity and Capital Resources 51 C. Research and Development, Patents and Licenses 52 D. Trend Information 52 E. Critical Accounting Estimates 52 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 53 A. Directors and Senior Management 53 B. Compensation 55 C. Board Practices 61 D. Employees 62 E. Share Ownership 62 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 63 A. Major Shareholders 63 B. Related Party Transactions 64 C. Interests of Experts and Counsel 65 ITEM 8. FINANCIAL INFORMATION. 65 A. Consolidated Statements and Other Financial Information. 65 B. Significant Changes 65 ITEM 9. THE OFFER AND LISTING 65 A. Offer and Listing Details 65 B. Plan of Distribution 65 C. Markets 66 D. Selling Shareholders 66 E. Dilution 66 F. Expenses of the Issue 66 ITEM 10.

Financial trend for ioneer Ltd from annual reports, periods 2020-06-30 to 2022-06-30: revenue went from 0 AUD (2020-06-30) to 0 AUD (2022-06-30); net income (loss) went from -5,446,000 AUD (2020-06-30) to -12,583,000 AUD (2022-06-30), a change of -131.1%; total assets went from 133,818,000 AUD (2020-06-30) to 309,238,000 AUD (2022-06-30), a change of +131.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1896084, tags Assets, ProfitLoss, Revenue; 3 periods shown, dashes mark figures ioneer Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on ioneer Ltd (CIK 1896084) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-29. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 75 8-K or 6-K reports in ioneer Ltd’s recent EDGAR index, the 4 listed here run from 2026-06-26 to 2026-08-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1896084 is on the EDGAR company page; the latest 20-F there is dated 2026-04-29 and the oldest filing in the recent index dates from 2021-12-07. Insider trades for ioneer Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

James fisher and sons plc bullish and bearish analyst opinions

The legal-form ending in “James fisher and sons plc” is the clue: “plc” is the UK public limited company form, so the company’s accounts are filed at Companies House. A company of that kind reports in the United Kingdom, so the place to read its annual report and announcements is Companies House and the London Stock Exchange RNS announcements — find-and-update.company-information.service.gov.uk.

No SEC filer could be matched to “James fisher and sons plc bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “James fisher and sons plc” appears in 179+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “james” (search terms considered: james, fisher, sons).

A broader EDGAR full-text search for the shorter phrase “James fisher sons” finds 4866+ filing documents; among the top 100, the filers mentioning it most are M FUND INC (CIK 0000948258) (38); VANGUARD WHITEHALL FUNDS (CIK 0001004655) (18); LINCOLN VARIABLE INSURANCE PRODUCTS TRUST (CIK 0000914036) (15). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in the United Kingdom. Companies there file with the London Stock Exchange and the FCA National Storage Mechanism rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “james” is therefore the the United Kingdom regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 100 most relevant full-text hits returned for “James fisher and sons plc”, filings range from 2014-04-01 to 2026-08-27. The filers whose documents mention it most often are JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 0000756913) (28 hits); FIDELITY INVESTMENT TRUST (CIK 0000744822) (21 hits); VARIABLE INSURANCE PRODUCTS FUND (CIK 0000356494) (19 hits); FIDELITY ADVISOR SERIES VIII (CIK 0000729218) (16 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 198+ entities whose registered name contains the word “james”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “james” 497, “fisher” 395, “sons” 82. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “james” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Jatt ii acquisition corp. bullish and bearish analyst opinions

This section ties “Jatt ii acquisition corp. bullish and bearish analyst opinions” to JATT II Acquisition Corp. (ticker JATT), SEC Central Index Key 2112446, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 425 dated 2026-10-01. Nothing here is a recommendation to trade the security.

Analyst ratings, price targets and “bullish” or “bearish” calls on JATT II Acquisition Corp. (CIK 2112446) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for JATT II Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 9 such filings (424B4, 425, S-1, S-1/A) appear in its recent index, the newest dated 2026-10-01.

Current reports. Of the 3 8-K or 6-K reports in JATT II Acquisition Corp.’s recent EDGAR index, the 3 listed here run from 2026-04-21 to 2026-06-29, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 46 recent EDGAR filings, JATT II Acquisition Corp. most often filed SCHEDULE 13G (7), 3 (7), 425 (6), CORRESP (6). A selection from 2026-09-10 to 2026-10-01:

The full record for CIK 2112446 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-03-13. Insider trades for JATT II Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jeld-wen holding, inc. bullish and bearish analyst opinions

This section ties “Jeld-wen holding, inc. bullish and bearish analyst opinions” to JELD-WEN Holding, Inc. (ticker JELD), SEC Central Index Key 1674335, an EDGAR registrant classified as “Millwood, Veneer, Plywood, & Structural Wood Members” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-23 by JELD-WEN Holding, Inc. (CIK 1674335) — source document:

The JELD-WEN family of brands includes JELD-WEN worldwide; LaCantina and VPI in North America; and Swedoor, DANA, and Kellpex in Europe. Our customers include wholesale distributors and retailers as well as individual contractors and consumers. Our business is highly diversified by distribution channel, geography, and construction application as illustrated below: 2025 Net Revenues $3.21 billion Channel Geography Construction Application (1) (1) The percentage of net revenues by construction application is management’s estimate based on the end markets into which our customers sell. As a leading global manufacturer of interior and exterior building products, we have invested significant capital to build a business platform that we believe is unique among our competitors.

Financial trend for JELD-WEN Holding, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $4.54 billion (2022-12-31) to $3.21 billion (2025-12-31), a change of -29.3%; net income (loss) went from $45.73 million (2022-12-31) to -$621.21 million (2025-12-31), a change of -1458.5%; total assets went from $3.50 billion (2022-12-31) to $2.10 billion (2025-12-31), a change of -39.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1674335, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures JELD-WEN Holding, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on JELD-WEN Holding, Inc. (CIK 1674335) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-03, and the most recent 10-K annual report was filed 2026-02-23. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 118 8-K or 6-K reports in JELD-WEN Holding, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-04 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1674335 is on the EDGAR company page; the latest 10-K there is dated 2026-02-23 and the oldest filing in the recent index dates from 2016-06-01. Insider trades for JELD-WEN Holding, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Julong holding limited bullish and bearish analyst opinions

This section ties “Julong holding limited bullish and bearish analyst opinions” to Julong Holding Ltd (ticker JLHL), SEC Central Index Key 2007846, an EDGAR registrant classified as “Services-Engineering Services” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a D dated 2026-10-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-02-13 by Julong Holding Ltd (CIK 2007846) — source document:

Julong Online (Beijing) Technology Development Co., Ltd. (formerly known as Meijiang Online (Beijing) Technology Development Co., Ltd.), or Julong Online, was established in June 1997 as a limited liability company incorporated under the laws of the PRC. Julong Online initially focused primarily on providing products and services to individual customers, such as individual proprietorships, property owners and residents, until May 2012 when our founder, chairman and chief executive officer, Mr. Jiaqi Hu, led our strategic transition to become a growth-oriented professional provider of intelligent integrated solutions, mainly serving public utilities, enterprises, commercial, multifamily properties and other institutional customers and focusing on complex and large-scale intelligent integrated engineering projects. To facilitate our offshore financing, we initiated a reorganization since July 2023.

Financial trend for Julong Holding Ltd from annual reports, periods 2023-09-30 to 2025-09-30: revenue went from 9,736,028 CNY (2024-09-30) to 255,740 CNY (2025-09-30), a change of -97.4%; net income (loss) went from 11,223,532 CNY (2023-09-30) to 26,152,199 CNY (2025-09-30), a change of +133.0%; total assets went from 173,078,241 CNY (2024-09-30) to 340,122,165 CNY (2025-09-30), a change of +96.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2007846, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Julong Holding Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Julong Holding Ltd (CIK 2007846) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-02-13. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 7 8-K or 6-K reports in Julong Holding Ltd’s recent EDGAR index, the 4 listed here run from 2026-06-16 to 2026-09-29, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2007846 is on the EDGAR company page; the latest 20-F there is dated 2026-02-13 and the oldest filing in the recent index dates from 2024-04-18. Insider trades for Julong Holding Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jupiter neurosciences, inc. bullish and bearish analyst opinions

This section ties “Jupiter neurosciences, inc. bullish and bearish analyst opinions” to JUPITER NEUROSCIENCES, INC. (ticker JUNS), SEC Central Index Key 1679628, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as Jupiter Orphan Therapeutics, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a S-8 dated 2026-10-13. Nothing here is a recommendation to trade the security.

Financial trend for JUPITER NEUROSCIENCES, INC. from annual reports, periods 2023-12-31 to 2025-12-31: revenue was tagged only for 2025-12-31 at $21,796; net income (loss) went from -$4.78 million (2023-12-31) to -$8.64 million (2025-12-31), a change of -80.7%; total assets went from $148,592 (2023-12-31) to $5.56 million (2025-12-31), a change of +3644.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1679628, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures JUPITER NEUROSCIENCES, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on JUPITER NEUROSCIENCES, INC. (CIK 1679628) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-04-01. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 27 8-K or 6-K reports in JUPITER NEUROSCIENCES, INC.’s recent EDGAR index, the 4 listed here run from 2026-08-24 to 2026-09-03, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 202 recent EDGAR filings, JUPITER NEUROSCIENCES, INC. most often filed CORRESP (40), 8-K (27), 4 (24), S-1/A (22). A selection from 2026-08-28 to 2026-10-13:

The full record for CIK 1679628 is on the EDGAR company page; the latest 10-K there is dated 2026-04-01 and the oldest filing in the recent index dates from 2016-07-15. Insider trades for JUPITER NEUROSCIENCES, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jw (cayman) therapeutics co. ltd bullish and bearish analyst opinions

This section ties “Jw (cayman) therapeutics co. ltd bullish and bearish analyst opinions” to JW (Cayman) Therapeutics Co. Ltd (ticker none listed), SEC Central Index Key 1817872, an EDGAR registrant classified as “no SIC description” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a D dated 2020-07-15. Nothing here is a recommendation to trade the security.

Analyst ratings, price targets and “bullish” or “bearish” calls on JW (Cayman) Therapeutics Co. Ltd (CIK 1817872) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

What kind of filer this is matters for “Jw (cayman) therapeutics co. ltd bullish and bearish analyst opinions”: JW (Cayman) Therapeutics Co. Ltd’s EDGAR record from 2020-07-15 to 2020-07-15 consists only of Form D notices of exempt private offerings, which means it raised money privately rather than registering shares for public trading. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

Other filings. Across its 1 recent EDGAR filings, JW (Cayman) Therapeutics Co. Ltd most often filed D (1). A selection from 2020-07-15 to 2020-07-15:

The full record for CIK 1817872 is on the EDGAR company page and the oldest filing in the recent index dates from 2020-07-15. Insider trades for JW (Cayman) Therapeutics Co. Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Kensington capital acquisition corp. iv bullish and bearish analyst opinions

This section ties “Kensington capital acquisition corp. iv bullish and bearish analyst opinions” to Amprius Technologies, Inc. (ticker AMPX, AMPX-WT), SEC Central Index Key 1899287, an EDGAR registrant classified as “Miscellaneous Electrical Machinery, Equipment & Supplies” and organised in DE, formerly known as Kensington Capital Acquisition Corp. IV. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a S-3ASR dated 2026-10-09. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-06 by Amprius Technologies, Inc. (CIK 1899287) — source document:

Amprius Technologies, Inc. develops, manufactures and markets lithium-ion batteries for mobility applications, including aviation, ground and marine vehicles. Our disruptive silicon anode technology is intended to enable batteries with high energy density, high power density and fast charging capabilities over a wide range of operating temperatures. This results in our batteries providing superior performance compared to conventional graphite lithium-ion batteries. Our silicon anodes are a direct drop-in replacement of the graphite anode in traditional lithium-ion batteries, and our manufacturing processes leverage the manufacturing processes for conventional lithium-ion batteries and the related supply chain. Currently, our batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems or “UAS”, such as drones and high-altitude pseudo satellites or “HAPS”.

Financial trend for Amprius Technologies, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $4.41 million (2022-12-31) to $73.01 million (2025-12-31), a change of +1556.0%; net income (loss) went from -$17.33 million (2022-12-31) to -$44.02 million (2025-12-31), a change of -154.0%; total assets went from $83.17 million (2022-12-31) to $156.89 million (2025-12-31), a change of +88.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1899287, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Amprius Technologies, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Amprius Technologies, Inc. (CIK 1899287) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-04, and the most recent 10-K annual report was filed 2026-03-06. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Amprius Technologies, Inc. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 89 such filings (424B3, 424B4, 424B7, 425, S-1) appear in its recent index, the newest dated 2026-10-09.

Current reports. Of the 63 8-K or 6-K reports in Amprius Technologies, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-17 to 2026-09-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1899287 is on the EDGAR company page; the latest 10-K there is dated 2026-03-06 and the oldest filing in the recent index dates from 2021-12-15. Insider trades for Amprius Technologies, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Kimberly-clark de méxico, s. a. b. de c. v. bullish and bearish analyst opinions

Read from its name, “Kimberly-clark de méxico, s. a. b. de c. v.” is a Mexico entity — “S.A.B. de C.V.” / “S.A. de C.V.” are Mexican company forms; the “B” denotes a listed stock company (sociedad anónima bursátil). Its accounts and exchange notices are published through the Bolsa Mexicana de Valores (BMV) issuer pages and CNBV (www.bmv.com.mx); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Kimberly-clark de méxico, s. a. b. de c. v. bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Kimberly-clark de méxico, s. a. b.”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “kimberly-clark” (search terms considered: kimberly-clark, xico).

A broader EDGAR full-text search for the shorter phrase “Kimberly-clark de m” finds 1752+ filing documents; among the top 100, the filers mentioning it most are MEXICO FUND INC (MXF) (CIK 0000065433) (91); KIMBERLY CLARK DE MEXICO S A DE C V /ADR/ (CIK 0000891002) (2); Citibank,N.A./ADR (JTGEY, JTGLF) (CIK 0001472033) (2). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Mexico. Companies there file with the Mexican Stock Exchange (BMV) and the CNBV rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “kimberly-clark” is therefore the Mexico regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 0 entities whose registered name contains the word “kimberly-clark”, so the business is most likely not registered with the SEC under that name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “kimberly-clark” 0, “xico” 0. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “kimberly-clark” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Lsi software s.a. bullish and bearish analyst opinions

What this search refers to. LSI Software S.A. is a Polish software company listed on the Warsaw Stock Exchange; its current and periodic reports are published through the GPW and ESPI system. Official source: www.gpw.pl.

No SEC filer could be matched to “Lsi software s.a. bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Lsi software s.a.”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “lsi” (search terms considered: lsi, software).

EDGAR’s company index has 25 entities whose registered name contains the word “lsi”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “lsi” 25, “software” 485. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “lsi”: A-LSI-11-FUND, A SERIES OF ANGELLIST-SDA-FUNDS, LLC (CIK 1737662), A-LSI-16-FUND, A SERIES OF ABSTRACT VENTURES SPECIAL OPPORTUNITIES, LLC (CIK 1751228), DELOS LSI CO-INVESTORS, LP (CIK 1951105); containing “software”: 10X SOFTWARE INC (CIK 1269673), 1VISION SOFTWARE INC (CIK 1164542), 2021 SOFTWARE FUND LLC (CIK 1887464). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: analyst views on “lsi” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Lyell immunopharma, inc. bullish and bearish analyst opinions

This section ties “Lyell immunopharma, inc. bullish and bearish analyst opinions” to Lyell Immunopharma, Inc. (ticker LYEL), SEC Central Index Key 1806952, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-12 by Lyell Immunopharma, Inc. (CIK 1806952) — source document:

We are a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with cancer. Our goal is to fully realize the curative potential of cell therapy for patients with hematologic malignancies and solid tumors. To achieve this, we are pioneering novel approaches designed to generate T‑cell therapies that drive long-lasting clinical responses. Our CAR T-cell product candidates start with the identification of promising cancer targets. We then engineer the patient’s own living immune cells and arm them with our innovative enhancements, including CAR constructs, technologies and manufacturing protocols that are designed to endow T cells with more potent cancer cell killing capabilities.

Financial trend for Lyell Immunopharma, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $84.68 million (2022-12-31) to $36,000 (2025-12-31), a change of -100.0%; net income (loss) went from -$183.12 million (2022-12-31) to -$274.45 million (2025-12-31), a change of -49.9%; total assets went from $937.56 million (2022-12-31) to $340.05 million (2025-12-31), a change of -63.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1806952, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Lyell Immunopharma, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Lyell Immunopharma, Inc. (CIK 1806952) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-06, and the most recent 10-K annual report was filed 2026-03-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 56 8-K or 6-K reports in Lyell Immunopharma, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-06 to 2026-09-10, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1806952 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2020-03-20. Insider trades for Lyell Immunopharma, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Matinas biopharma holdings, inc. bullish and bearish analyst opinions

This section ties “Matinas biopharma holdings, inc. bullish and bearish analyst opinions” to Matinas BioPharma Holdings, Inc. (ticker MTNB), SEC Central Index Key 1582554, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-28. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-31 by Matinas BioPharma Holdings, Inc. (CIK 1582554) — source document:

Matinas BioPharma Holdings, Inc. (“Matinas” or the “Company”) is a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using our lipid nanocrystal (“LNC”) platform delivery technology (the “LNC Platform”). Our lead product candidate is MAT2203 (oral amphotericin B), a highly potent antifungal drug which, by virtue of LNC delivery, has been made oral, safe, and well-tolerated for prolonged administration in patients with life-threatening invasive fungal infections. Following the successful EnACT Phase 2 trial in the treatment of cryptococcal meningitis, MAT2203 is now positioned for a single, Phase 3 registration trial (the “ORALTO trial”) in support of a New Drug Application (“NDA”) for the treatment of invasive aspergillosis in patients with limited treatment options.

Financial trend for Matinas BioPharma Holdings, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$21.00 million (2022-12-31) to -$10.35 million (2025-12-31), a change of +50.7%; total assets went from $44.82 million (2022-12-31) to $7.21 million (2025-12-31), a change of -83.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1582554, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Matinas BioPharma Holdings, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Matinas BioPharma Holdings, Inc. (CIK 1582554) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2024-08-14, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 137 8-K or 6-K reports in Matinas BioPharma Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-24 to 2026-09-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1582554 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2013-07-25. Insider trades for Matinas BioPharma Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Medalist diversified reit, inc. bullish and bearish analyst opinions

This section ties “Medalist diversified reit, inc. bullish and bearish analyst opinions” to Medalist Diversified, Inc. (ticker MDRR), SEC Central Index Key 1654595, an EDGAR registrant classified as “Real Estate Investment Trusts” and organised in MD, formerly known as Medalist Diversified REIT, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a PRE 14C dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-02 by Medalist Diversified, Inc. (CIK 1654595) — source document:

As used in this Annual Report, unless the context otherwise requires, references to “we,” “our,” “us,” and “our company” refer to Medalist Diversified, Inc., a Maryland corporation, together with our consolidated subsidiaries, including Medalist Diversified Holdings, LP, a Delaware limited partnership of which we are the sole general partner, except where it is clear from the context that the term only means Medalist Diversified, Inc. Overview Medalist Diversified, Inc. was formed in 2015 as a Maryland corporation, to acquire, reposition, renovate, lease and manage income-producing properties. We own our investment properties and other investments through our operating partnership, Medalist Diversified Holdings, L.P., a Delaware limited partnership (the “Operating Partnership”) which was formed on September 29, 2015.

Financial trend for Medalist Diversified, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $11.09 million (2022-12-31) to $10.40 million (2025-12-31), a change of -6.3%; net income (loss) went from -$4.77 million (2022-12-31) to -$2.39 million (2025-12-31), a change of +49.9%; total assets went from $87.92 million (2022-12-31) to $77.74 million (2025-12-31), a change of -11.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1654595, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Medalist Diversified, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Medalist Diversified, Inc. (CIK 1654595) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2024-04-08, and the most recent 10-K annual report was filed 2026-03-02. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 152 8-K or 6-K reports in Medalist Diversified, Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-18 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1654595 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-28 and the oldest filing in the recent index dates from 2015-10-05. Insider trades for Medalist Diversified, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Meshflow acquisition corp. bullish and bearish analyst opinions

This section ties “Meshflow acquisition corp. bullish and bearish analyst opinions” to Meshflow Acquisition Corp (ticker MESH, MESHU, MESHW), SEC Central Index Key 2081468, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 425 dated 2026-09-08. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-17 by Meshflow Acquisition Corp (CIK 2081468) — source document:

References in this Form 10-K to “we,” “us,” “our” or the “Company” refer to Apex Treasury Corporation. References to our “management” or our “management team” refer to our officers and directors. Introduction We are a blank check company incorporated on July 22, 2026 as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We have 24 months from the closing of our initial public offering (“IPO” or “Initial Public Offering”), or until such earlier liquidation date as our board of directors may approve (the “Completion Window”), to complete our initial Business Combination.

Financial trend for Meshflow Acquisition Corp from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from $2.79 million (2026-03-31) to $2.90 million (2026-06-30), a change of +3.8%; total assets went from $349.86 million (2026-03-31) to $352.82 million (2026-06-30), a change of +0.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2081468, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Meshflow Acquisition Corp did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Meshflow Acquisition Corp (CIK 2081468) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-17. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Meshflow Acquisition Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 4 such filings (424B4, 425, S-1, S-1/A) appear in its recent index, the newest dated 2026-09-08.

Current reports. Of the 4 8-K or 6-K reports in Meshflow Acquisition Corp’s recent EDGAR index, the 4 listed here run from 2025-12-15 to 2026-09-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2081468 is on the EDGAR company page; the latest 10-K there is dated 2026-03-17 and the oldest filing in the recent index dates from 2025-09-10. Insider trades for Meshflow Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Metalpha technology holding limited bullish and bearish analyst opinions

This section ties “Metalpha technology holding limited bullish and bearish analyst opinions” to Metalpha Technology Holding Ltd (ticker MATH), SEC Central Index Key 1682241, an EDGAR registrant classified as “Finance Services” and organised in Hong Kong, formerly known as Dragon Victory International Ltd. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-09-29. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-08-06 by Metalpha Technology Holding Ltd (CIK 1682241) — source document:

We are not an operating company but a Cayman Islands holding company. Currently, we are a provider of digital asset services. We were incorporated in the Cayman Islands on June 19, 2015. Our wholly-owned subsidiary, Sweet Lollipop, was incorporated in the British Virgin Islands on May 8, 2014. Metalpha HK was incorporated in Hong Kong on May 2, 2015. Metalpha Limited was incorporated in the British Virgin Islands on October 29, 2021. In November 2022, we changed our corporate name from Dragon Victory International Limited to Metalpha Technology Holding Limited. On August 22, 2019, we incorporated a wholly owned subsidiary, Zhejiang Shengqian Business Consulting Co., Ltd. (“Shengqian”). We dissolved Shengqian on August 19, 2021.

Financial trend for Metalpha Technology Holding Ltd from annual reports, periods 2018-03-31 to 2021-03-31: revenue went from $4.28 million (2018-03-31) to $225,749 (2021-03-31), a change of -94.7%; net income (loss) went from $193,131 (2018-03-31) to -$5.15 million (2021-03-31), a change of -2765.6%; total assets went from $13.02 million (2018-03-31) to $15.63 million (2021-03-31), a change of +20.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1682241, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Metalpha Technology Holding Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Metalpha Technology Holding Ltd (CIK 1682241) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-08-06. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 109 8-K or 6-K reports in Metalpha Technology Holding Ltd’s recent EDGAR index, the 4 listed here run from 2026-03-09 to 2026-09-29, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1682241 is on the EDGAR company page; the latest 20-F there is dated 2026-08-06 and the oldest filing in the recent index dates from 2016-08-22. Insider trades for Metalpha Technology Holding Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Modus therapeutics holding ab bullish and bearish analyst opinions

“AB (publ)” marks a Swedish public limited company (aktiebolag) allowed to offer shares to the public. The name “Modus therapeutics holding ab” therefore points to a company organised in Sweden, and its official disclosures are on Nasdaq Stockholm / Spotlight announcements and the Swedish FSA (Finansinspektionen) register (www.fi.se), not on EDGAR.

No SEC filer could be matched to “Modus therapeutics holding ab bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Modus therapeutics holding ab”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “modus” (search terms considered: modus, therapeutics, holding).

Even the shorter phrase “Modus therapeutics holding” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (modus, therapeutics, holding) point to a business outside the SEC system or one known by another legal name.

The wording suggests a business based in Sweden. Companies there file with Nasdaq Stockholm and Finansinspektionen rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “modus” is therefore the Sweden regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 9 entities whose registered name contains the word “modus”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “modus” 9, “therapeutics” 464, “holding” 487. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “modus” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Moolec science s.a. bullish and bearish analyst opinions

This section ties “Moolec science s.a. bullish and bearish analyst opinions” to Moolec Science SA (ticker MLEC, MLECW), SEC Central Index Key 1937737, an EDGAR registrant classified as “Food and Kindred Products” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-21. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2025-12-29 by Moolec Science SA (CIK 1937737) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 67 A. Operating Results 67 B. Liquidity and Capital Resources 77 C. Research and Development, Patents and Licenses, etc. 81 D. Trend Information 81 E. Critical Accounting Estimates 81 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 81 A. Directors and Senior Management 81 B. Compensation 83 C. Board Practices 84 D. Employees 86 E. Share Ownership 86 F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation 87 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 87 A. Major Shareholders 87 B. Related Party Transactions 87 C. Interests of Experts and Counsel 90 i ITEM 8. FINANCIAL INFORMATION 90 A. Consolidated Statements and Other Financial Information 90 B. Significant Changes 91 ITEM 9.

Financial trend for Moolec Science SA from annual reports, periods 2022-06-30 to 2024-06-30: revenue went from $905,049 (2023-06-30) to $5.63 million (2024-06-30), a change of +521.5%; net income (loss) went from -$4.53 million (2022-06-30) to -$7.31 million (2024-06-30), a change of -61.5%; total assets went from $5.69 million (2022-06-30) to $34.79 million (2024-06-30), a change of +511.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1937737, tags Assets, ProfitLoss, Revenue; 3 periods shown, dashes mark figures Moolec Science SA did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Moolec Science SA (CIK 1937737) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2025-12-29. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 65 8-K or 6-K reports in Moolec Science SA’s recent EDGAR index, the 4 listed here run from 2026-07-14 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1937737 is on the EDGAR company page; the latest 20-F there is dated 2025-12-29 and the oldest filing in the recent index dates from 2022-08-12. Insider trades for Moolec Science SA appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nasus pharma ltd. bullish and bearish analyst opinions

This section ties “Nasus pharma ltd. bullish and bearish analyst opinions” to Nasus Pharma Ltd (ticker NSRX), SEC Central Index Key 2029039, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in Israel. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a S-8 dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-03-25 by Nasus Pharma Ltd (CIK 2029039) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 102 A. Operating Results 102 B. Liquidity and Capital Resources 105 C. Research and development, patents and licenses, etc. 107 D. Trend Information 107 E. Critical Accounting Estimates 108 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 110 A. Directors and Senior Management 110 B. Compensation 113 C. Board Practices 117 D. Employees 130 E. Share Ownership 130 F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation 132 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 132 A. Major Shareholders 132 B. Related Party Transactions 134 C. Interests of Experts and Counsel 138 ITEM 8. FINANCIAL INFORMATION 138 A. Consolidated Statements and Other Financial Information 138 B. Significant Changes 138 ITEM 9.

Financial trend for Nasus Pharma Ltd from annual reports, periods 2023-12-31 to 2025-12-31: revenue was tagged only for 2025-12-31 at $1.24 billion; net income (loss) went from -$1.05 million (2023-12-31) to -$5.86 million (2025-12-31), a change of -457.2%; total assets went from $717,000 (2024-12-31) to $5.00 million (2025-12-31), a change of +597.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2029039, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Nasus Pharma Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Nasus Pharma Ltd (CIK 2029039) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-03-25. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 26 8-K or 6-K reports in Nasus Pharma Ltd’s recent EDGAR index, the 4 listed here run from 2026-09-04 to 2026-10-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2029039 is on the EDGAR company page; the latest 20-F there is dated 2026-03-25 and the oldest filing in the recent index dates from 2024-08-30. Insider trades for Nasus Pharma Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Neuphoria therapeutics inc. bullish and bearish analyst opinions

This section ties “Neuphoria therapeutics inc. bullish and bearish analyst opinions” to Neuphoria Therapeutics Inc. (ticker NEUP), SEC Central Index Key 1191070, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in Australia, formerly known as BIONOMICS LIMITED/FI. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-23. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-09-18 by Neuphoria Therapeutics Inc. (CIK 1191070) — source document:

Neuphoria Therapeutics Inc. is a Delaware corporation and a clinical-stage biotechnology company. Following the results of our Phase 3 AFFIRM-1 trial and the restructuring actions taken during fiscal 2026, our activities are focused on completing the proposed merger with Scancell Holdings plc ("Scancell"), preserving cash, maintaining our public-company and contractual obligations, and managing our intellectual property and economic interests in partnered programs. We are currently conducting limited active internal research and development activities focused on our alpha7 nicotinic acetylcholine receptor negative allosteric modulator portfolio. Our lead product candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor. On October 20, 2025, we announced that AFFIRM-1, our Phase 3 trial of BNC210 for the acute treatment of social anxiety disorder ("SAD"), did not meet its primary endpoint, and secondary endpoint analysis did not show statistically significant differences or improvement over placebo.

Financial trend for Neuphoria Therapeutics Inc. from annual reports, periods 2023-06-30 to 2026-06-30: revenue went from $15.65 million (2025-06-30) to $1.17 million (2026-06-30), a change of -92.5%; net income (loss) went from -$21.38 million (2023-06-30) to -$13.45 million (2026-06-30), a change of +37.1%; total assets went from $28.56 million (2023-06-30) to $28.71 million (2026-06-30), a change of +0.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1191070, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Neuphoria Therapeutics Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Neuphoria Therapeutics Inc. (CIK 1191070) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2025-05-20, and the most recent 10-K annual report was filed 2026-09-18. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 68 8-K or 6-K reports in Neuphoria Therapeutics Inc.’s recent EDGAR index, the 4 listed here run from 2026-01-08 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1191070 is on the EDGAR company page; the latest 10-K there is dated 2026-09-18 and the oldest filing in the recent index dates from 2002-09-11. Insider trades for Neuphoria Therapeutics Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Newtekone, inc. bullish and bearish analyst opinions

This section ties “Newtekone, inc. bullish and bearish analyst opinions” to NewtekOne, Inc. (ticker NEWT, NEWTI, NEWTG, NEWTH, NEWTO, NEWTP), SEC Central Index Key 1587987, an EDGAR registrant classified as “National Commercial Banks” and organised in MD, formerly known as Newtek Business Services Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-21. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-10 by NewtekOne, Inc. (CIK 1587987) — source document:

Prior to January 6, 2023 when we acquired Newtek Bank and converted to a financial holding company, we operated as an internally managed non-diversified closed-end management investment company that was regulated as a BDC under the 1940 Act, and was treated as a RIC under the Code for U.S. federal income tax purposes. See “Executive Overview - Conversion to a Financial Holding Company. ” In addition to our bank subsidiary, Newtek Bank and its consolidated subsidiary, SBL, the following are our consolidated non-bank direct and indirect subsidiaries: Newtek Small Business Finance, LLC (NSBF); Newtek Business Services Holdco 6, Inc. d/b/a Newtek ALP Holdings (NALH); Newtek Merchant Solutions, LLC (NMS) and its subsidiary Mobil Money, LLC; CDS Business Services, Inc. d/b/a Newtek Business Credit Solutions (NBC); PMTWorks Payroll, LLC d/b/a Newtek Payroll and Benefits Solutions (PMT); Newtek Insurance Agency, LLC (NIA); Titanium Asset Management LLC (TAM); and POS on Cloud, LLC, d/b/a Newtek Payment Systems (POS).

Financial trend for NewtekOne, Inc. from annual reports, periods 2023-09-30 to 2025-12-31: net income (loss) went from $47.33 million (2023-12-31) to $60.51 million (2025-12-31), a change of +27.9%; total assets went from $1.39 billion (2023-09-30) to $2.74 billion (2025-12-31), a change of +97.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1587987, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures NewtekOne, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on NewtekOne, Inc. (CIK 1587987) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-09-14, and the most recent 10-K annual report was filed 2026-03-10. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 281 8-K or 6-K reports in NewtekOne, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-06 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1587987 is on the EDGAR company page; the latest 10-K there is dated 2026-03-10 and the oldest filing in the recent index dates from 2015-09-08. Insider trades for NewtekOne, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nexmetals mining corp. bullish and bearish analyst opinions

This section ties “Nexmetals mining corp. bullish and bearish analyst opinions” to NexMetals Mining Corp. (ticker NEXM), SEC Central Index Key 795800, an EDGAR registrant classified as “Metal Mining” and organised in British Columbia, Canada, formerly known as Premium Resources Ltd. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-20. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-13 by NexMetals Mining Corp. (CIK 795800) — source document:

The principal assets of NEXM are the Selebi and Selebi North copper-nickel-cobalt (“ Cu-Ni-Co ”) mines in Botswana and related infrastructure (together, the “ Selebi Mines ”), as well as the Cu-Ni-Co-PGE Selkirk mine in Botswana, together with associated infrastructure and four surrounding prospecting licences (collectively, the “ Selkirk Mine ” and together with the Selebi Mines, the “ Mines ”). NEXM is committed to governance through transparency, accountability, and open communication among NEXM’s team and stakeholders. The Common Shares of NEXM (“ Common Shares ”) are listed for trading on the Nasdaq Capital Market (the “ Nasdaq ”) and on the TSX Venture Exchange (the “ TSXV ”) under the symbol “NEXM”.

Financial trend for NexMetals Mining Corp. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -27,306,350 CAD (2022-12-31) to -59,086,325 CAD (2025-12-31), a change of -116.4%; total assets went from 18,411,643 CAD (2022-12-31) to 98,518,580 CAD (2025-12-31), a change of +435.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 795800, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures NexMetals Mining Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on NexMetals Mining Corp. (CIK 795800) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-13. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 186 8-K or 6-K reports in NexMetals Mining Corp.’s recent EDGAR index, the 4 listed here run from 2026-08-17 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 795800 is on the EDGAR company page; the latest 10-K/A there is dated 2026-05-13 and the oldest filing in the recent index dates from 2002-06-25. Insider trades for NexMetals Mining Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nordic iron ore ab (publ) bullish and bearish analyst opinions

“AB (publ)” marks a Swedish public limited company (aktiebolag) allowed to offer shares to the public. The name “Nordic iron ore ab (publ)” therefore points to a company organised in Sweden, and its official disclosures are on Nasdaq Stockholm / Spotlight announcements and the Swedish FSA (Finansinspektionen) register (www.fi.se), not on EDGAR.

No SEC filer could be matched to “Nordic iron ore ab (publ) bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Nordic iron ore ab publ”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “nordic” (search terms considered: nordic, iron, ore).

Even the shorter phrase “Nordic iron ore” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (nordic, iron, ore) point to a business outside the SEC system or one known by another legal name.

The wording suggests a business based in Sweden. Companies there file with Nasdaq Stockholm and Finansinspektionen rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “nordic” is therefore the Sweden regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 116 entities whose registered name contains the word “nordic”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “nordic” 116, “iron” 394, “ore” 56. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “nordic” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Novabridge biosciences bullish and bearish analyst opinions

This section ties “Novabridge biosciences bullish and bearish analyst opinions” to NovaBridge Biosciences (ticker NBP), SEC Central Index Key 1778016, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in Cayman Islands, formerly known as I-Mab. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-23. Nothing here is a recommendation to trade the security.

Financial trend for NovaBridge Biosciences from annual reports, periods 2020-12-31 to 2023-12-31: revenue went from 1,542,668,000 CNY (2020-12-31) to 27,644,000 CNY (2023-12-31), a change of -98.2%; net income (loss) went from 470,915,000 CNY (2020-12-31) to -1,465,694,000 CNY (2023-12-31), a change of -411.2%; total assets went from 6,333,793,000 CNY (2020-12-31) to 2,612,967,000 CNY (2023-12-31), a change of -58.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1778016, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures NovaBridge Biosciences did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on NovaBridge Biosciences (CIK 1778016) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-07. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 165 8-K or 6-K reports in NovaBridge Biosciences’s recent EDGAR index, the 4 listed here run from 2026-09-08 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 327 recent EDGAR filings, NovaBridge Biosciences most often filed 6-K (165), 144 (21), 3 (20), 4 (16). A selection from 2026-09-10 to 2026-10-19:

The full record for CIK 1778016 is on the EDGAR company page; the latest 20-F there is dated 2026-04-07 and the oldest filing in the recent index dates from 2019-07-29. Insider trades for NovaBridge Biosciences appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Onewater marine inc. bullish and bearish analyst opinions

This section ties “Onewater marine inc. bullish and bearish analyst opinions” to OneWater Marine Inc. (ticker ONEW), SEC Central Index Key 1772921, an EDGAR registrant classified as “Retail-Auto & Home Supply Stores” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-05. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2025-12-15 by OneWater Marine Inc. (CIK 1772921) — source document:

Except as otherwise indicated or required by the context, all references in this Annual Report on Form 10-K to the “Company,” “OneWater,” “we,” “us” or “our” relate to OneWater Inc. and its consolidated subsidiaries. Overview We believe that we are one of the largest and fastest-growing marine retailers in the United States with 95 dealership locations, 9 distribution centers/warehouses and multiple online marketplaces as of September 30, 2025. Our retail locations are located in highly attractive markets throughout the Southeast, Gulf Coast, Mid-Atlantic and Northeast, many of which are in the top twenty states for marine retail expenditures. We believe that we are a market leader by volume in sales of premium boats in many of the markets in which we operate.

Financial trend for OneWater Marine Inc. from annual reports, periods 2022-09-30 to 2025-09-30: revenue went from $1.74 billion (2022-09-30) to $1.87 billion (2025-09-30), a change of +7.3%; net income (loss) went from $130.94 million (2022-09-30) to -$114.58 million (2025-09-30), a change of -187.5%; total assets went from $1.50 billion (2022-09-30) to $1.40 billion (2025-09-30), a change of -6.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1772921, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures OneWater Marine Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on OneWater Marine Inc. (CIK 1772921) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-30, and the most recent 10-K annual report was filed 2025-12-15. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 92 8-K or 6-K reports in OneWater Marine Inc.’s recent EDGAR index, the 4 listed here run from 2026-02-19 to 2026-09-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1772921 is on the EDGAR company page; the latest 10-K there is dated 2025-12-15 and the oldest filing in the recent index dates from 2019-04-26. Insider trades for OneWater Marine Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Permrock royalty trust bullish and bearish analyst opinions

This section ties “Permrock royalty trust bullish and bearish analyst opinions” to PermRock Royalty Trust (ticker PRT), SEC Central Index Key 1724009, an EDGAR registrant classified as “Crude Petroleum & Natural Gas” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-20. Nothing here is a recommendation to trade the security.

Analyst ratings, price targets and “bullish” or “bearish” calls on PermRock Royalty Trust (CIK 1724009) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-10-20, and the most recent 10-K annual report was filed 2026-03-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 113 8-K or 6-K reports in PermRock Royalty Trust’s recent EDGAR index, the 4 listed here run from 2026-07-21 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 301 recent EDGAR filings, PermRock Royalty Trust most often filed 8-K (113), 4 (106), 10-Q (26), 10-K (8). A selection from 2025-08-13 to 2026-08-14:

The full record for CIK 1724009 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2017-12-14. Insider trades for PermRock Royalty Trust appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pliant therapeutics, inc. bullish and bearish analyst opinions

This section ties “Pliant therapeutics, inc. bullish and bearish analyst opinions” to PLIANT THERAPEUTICS, INC. (ticker PLRX), SEC Central Index Key 1746473, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-02. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-11 by PLIANT THERAPEUTICS, INC. (CIK 1746473) — source document:

We are a clinical-stage biopharmaceutical company focused on discovering and developing integrin-based therapeutics. Our lead program is focused on the development of treatments for solid tumors by inhibiting integrin-mediated activation of transforming growth factor-β (TGF-β). We have applied our deep understanding of integrin biology, along with our medicinal chemistry and translational medicine expertise to develop a proprietary drug discovery platform that we believe has broad applicability across multiple areas of disease. Our wholly owned lead product candidate, PLN-101095, is an oral, small molecule, dual selective inhibitor of αvβ8 and αvβ1 integrins in development for the treatment of solid tumors. In 2025, we announced positive data from a Phase 1 open-label dose-escalation trial of PLN-101095 as monotherapy and in combination with the immunotherapy pembrolizumab in patients with solid tumors that are resistant to immune checkpoint inhibitors.

Financial trend for PLIANT THERAPEUTICS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $9.69 million (2022-12-31) to $0 (2025-12-31), a change of -100.0%; net income (loss) went from -$123.32 million (2022-12-31) to -$149.34 million (2025-12-31), a change of -21.1%; total assets went from $350.61 million (2022-12-31) to $225.23 million (2025-12-31), a change of -35.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1746473, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures PLIANT THERAPEUTICS, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on PLIANT THERAPEUTICS, INC. (CIK 1746473) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11, and the most recent 10-K annual report was filed 2026-03-11. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 66 8-K or 6-K reports in PLIANT THERAPEUTICS, INC.’s recent EDGAR index, the 4 listed here run from 2026-05-11 to 2026-08-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1746473 is on the EDGAR company page; the latest 10-K there is dated 2026-03-11 and the oldest filing in the recent index dates from 2018-07-20. Insider trades for PLIANT THERAPEUTICS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Posco dx company ltd. bullish and bearish analyst opinions

Read from its name, “Posco dx company ltd.” is a a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada) entity — “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. Its accounts and exchange notices are published through that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Posco dx company ltd. bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Posco dx company ltd.” appears in 283+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “posco” (search terms considered: posco).

Even the shorter phrase “Posco dx ltd.” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (posco) point to a business outside the SEC system or one known by another legal name.

In the 100 most relevant full-text hits returned for “Posco dx company ltd.”, filings range from 2023-06-26 to 2026-10-23. The filers whose documents mention it most often are John Hancock Funds II (CIK 0001331971) (26 hits); Dimensional ETF Trust (CIK 0001816125) (24 hits); John Hancock Exchange-Traded Fund Trust (CIK 0001478482) (23 hits); iShares, Inc. (CIK 0000930667) (6 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 4 entities whose registered name contains the word “posco”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “posco” 4. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “posco” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Prologis property mexico, s.a. de c.v. bullish and bearish analyst opinions

“S.A.B. de C.V.” / “S.A. de C.V.” are Mexican company forms; the “B” denotes a listed stock company (sociedad anónima bursátil). The name “Prologis property mexico, s.a. de c.v.” therefore points to a company organised in Mexico, and its official disclosures are on the Bolsa Mexicana de Valores (BMV) issuer pages and CNBV (www.bmv.com.mx), not on EDGAR.

No SEC filer could be matched to “Prologis property mexico, s.a. de c.v. bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Prologis property mexico, s.a. de c.v.” appears in 2114+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “prologis” (search terms considered: prologis, property, mexico).

A broader EDGAR full-text search for the shorter phrase “Prologis property mexico” finds 10000+ filing documents; among the top 100, the filers mentioning it most are Franklin Templeton ETF Trust (CIK 0001655589) (16); MATTHEWS INTERNATIONAL FUNDS (CIK 0000923184) (15); iShares, Inc. (CIK 0000930667) (15). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Mexico. Companies there file with the Mexican Stock Exchange (BMV) and the CNBV rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “prologis” is therefore the Mexico regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 100 most relevant full-text hits returned for “Prologis property mexico, s.a. de c.v.”, filings range from 2015-08-27 to 2026-10-23. The filers whose documents mention it most often are AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) (CIK 0001112996) (18 hits); Invesco Exchange-Traded Fund Trust II (CIK 0001378872) (13 hits); Investment Managers Series Trust (CIK 0001318342) (9 hits); VICTORY PORTFOLIOS (CIK 0000802716) (8 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 57 entities whose registered name contains the word “prologis”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “prologis” 57, “property” 487, “mexico” 352. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “prologis” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pt apollo global interactive tbk bullish and bearish analyst opinions

The legal-form ending in “Pt apollo global interactive tbk” is the clue: “PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. A company of that kind reports in Indonesia, so the place to read its annual report and announcements is the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK — www.idx.co.id.

No SEC filer could be matched to “Pt apollo global interactive tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pt apollo global interactive tbk” appears in 6 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “apollo” (search terms considered: apollo, global, interactive).

A broader EDGAR full-text search for the shorter phrase “Pt apollo global” finds 6 filing documents; among the top 6, the filers mentioning it most are Dimensional ETF Trust (CIK 0001816125) (5); DFA INVESTMENT DIMENSIONS GROUP INC (CIK 0000355437) (1). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “apollo” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 6 most relevant full-text hits returned for “Pt apollo global interactive tbk”, filings range from 2026-06-29 to 2026-09-24. The filers whose documents mention it most often are Dimensional ETF Trust (CIK 0001816125) (5 hits); DFA INVESTMENT DIMENSIONS GROUP INC (CIK 0000355437) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 199+ entities whose registered name contains the word “apollo”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “apollo” 484, “global” 442, “interactive” 450. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “apollo” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pt bank victoria international tbk bullish and bearish analyst opinions

Read from its name, “Pt bank victoria international tbk” is a Indonesia entity — “PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. Its accounts and exchange notices are published through the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK (www.idx.co.id); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Pt bank victoria international tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pt bank victoria international tbk” appears in 8 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “victoria” (search terms considered: bank, victoria, international).

A broader EDGAR full-text search for the shorter phrase “Pt bank victoria” finds 35 filing documents; among the top 35, the filers mentioning it most are PERUSAHAAN PERSEROAN PERSERO PT TELEKOMUNIKASI INDONESIA TBK (TLK) (CIK 0001001807) (8); VANGUARD INTERNATIONAL EQUITY INDEX FUNDS (CIK 0000857489) (3); AMERICAN CENTURY ETF TRUST (CIK 0001710607) (3). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “victoria” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 8 most relevant full-text hits returned for “Pt bank victoria international tbk”, filings range from 2008-05-23 to 2009-10-30. The filers whose documents mention it most often are PERUSAHAAN PERSEROAN PERSERO PT TELEKOMUNIKASI INDONESIA TBK (TLK) (CIK 0001001807) (8 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 195+ entities whose registered name contains the word “victoria”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “bank” 459, “victoria” 235, “international” 458. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “victoria” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pt victoria care indonesia tbk bullish and bearish analyst opinions

“PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. The name “Pt victoria care indonesia tbk” therefore points to a company organised in Indonesia, and its official disclosures are on the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK (www.idx.co.id), not on EDGAR.

No SEC filer could be matched to “Pt victoria care indonesia tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pt victoria care indonesia tbk” appears in 15 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “victoria” (search terms considered: victoria, care, indonesia).

A broader EDGAR full-text search for the shorter phrase “Pt victoria care” finds 15 filing documents; among the top 15, the filers mentioning it most are Bowen Acquisition Corp (BOWN, BOWNR, BOWNU) (CIK 0001973056) (9); Qianzhi Group Holding (Cayman) Ltd (CIK 0002038482) (6); Squirrel Enlivened International Co., Ltd (CIK 0002033684) (4). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 15 most relevant full-text hits returned for “Pt victoria care indonesia tbk”, filings range from 2024-05-10 to 2025-05-02. The filers whose documents mention it most often are Bowen Acquisition Corp (BOWN, BOWNR, BOWNU) (CIK 0001973056) (9 hits); Qianzhi Group Holding (Cayman) Ltd (CIK 0002038482) (6 hits); Squirrel Enlivened International Co., Ltd (CIK 0002033684) (4 hits); Squirrel Enlivened International Co., Ltd (SQEI) (CIK 0002033684) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

Word by word, the number of EDGAR registrant names containing each term of this search is: “victoria” 235, “care” 484, “indonesia” 36. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Updated Oct 25, 2026 ET

Sigma foods, s.a.b. de c.v. bullish and bearish analyst opinions

The legal-form ending in “Sigma foods, s.a.b. de c.v.” is the clue: “S.A.B. de C.V.” / “S.A. de C.V.” are Mexican company forms; the “B” denotes a listed stock company (sociedad anónima bursátil). A company of that kind reports in Mexico, so the place to read its annual report and announcements is the Bolsa Mexicana de Valores (BMV) issuer pages and CNBV — www.bmv.com.mx.

No SEC filer could be matched to “Sigma foods, s.a.b. de c.v. bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Sigma foods, s.a.b. de c.v.” appears in 198+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “sigma” (search terms considered: sigma, foods).

A broader EDGAR full-text search for the shorter phrase “Sigma foods s.a.b.” finds 198+ filing documents; among the top 100, the filers mentioning it most are Invesco Exchange-Traded Fund Trust II (CIK 0001378872) (28); NORTHERN FUNDS (CIK 0000916620) (15); iShares, Inc. (CIK 0000930667) (12). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Mexico. Companies there file with the Mexican Stock Exchange (BMV) and the CNBV rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “sigma” is therefore the Mexico regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 100 most relevant full-text hits returned for “Sigma foods, s.a.b. de c.v.”, filings range from 2026-02-26 to 2026-10-23. The filers whose documents mention it most often are Invesco Exchange-Traded Fund Trust II (CIK 0001378872) (28 hits); NORTHERN FUNDS (CIK 0000916620) (15 hits); iShares, Inc. (CIK 0000930667) (12 hits); Ashmore Funds (CIK 0001498498) (12 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 186+ entities whose registered name contains the word “sigma”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “sigma” 258, “foods” 474. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “sigma” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Smartstop self storage reit inc bullish and bearish analyst opinions

This section ties “Smartstop self storage reit inc bullish and bearish analyst opinions” to SmartStop Self Storage REIT, Inc. (ticker SMA), SEC Central Index Key 1585389, an EDGAR registrant classified as “Real Estate Investment Trusts” and organised in MD, formerly known as Strategic Storage Trust II, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-27 by SmartStop Self Storage REIT, Inc. (CIK 1585389) — source document:

SmartStop Self Storage REIT, Inc., a Maryland corporation (the “Company”), is a self-managed and fully-integrated self storage real estate investment trust (“REIT”), formed on January 8, 2013 under the Maryland General Corporation Law. Our year-end is December 31. As used in this report, “we,” “us,” “our,” and “Company” refer to SmartStop Self Storage REIT, Inc. and each of our subsidiaries. Our Common Stock began trading on the New York Stock Exchange (the “NYSE”) under the ticker symbol “SMA” on April 2, 2025. Business Objectives and Strategy We focus on the acquisition, ownership, and operation of self storage properties located primarily within the top 100 metropolitan statistical areas, or MSAs, throughout the United States and Canada.

Financial trend for SmartStop Self Storage REIT, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$2.75 million (2023-12-31) to -$8.76 million (2025-12-31), a change of -218.9%; total assets went from $1.95 billion (2022-12-31) to $2.43 billion (2025-12-31), a change of +24.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1585389, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures SmartStop Self Storage REIT, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SmartStop Self Storage REIT, Inc. (CIK 1585389) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-05, and the most recent 10-K annual report was filed 2026-02-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 266 8-K or 6-K reports in SmartStop Self Storage REIT, Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-03 to 2026-10-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1585389 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2013-09-04. Insider trades for SmartStop Self Storage REIT, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Soulpower acquisition corp. bullish and bearish analyst opinions

This section ties “Soulpower acquisition corp. bullish and bearish analyst opinions” to Soulpower Acquisition Corp. (ticker SOUL, SOUL-RI, SOUL-UN), SEC Central Index Key 2025608, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands, formerly known as Soulpower Acquisition Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 425 dated 2026-09-03. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-27 by Soulpower Acquisition Corp. (CIK 2025608) — source document:

Certain Terms Unless otherwise stated in this annual report or the context otherwise requires, references to: ● “we,” “us,” “company,” or “our company” are to Soulpower Acquisition Corporation, a Cayman Islands exempted company; ● “Cantor” are to Cantor Fitzgerald & Co.: ● “Companies Act” or “Companies Law” are to the Companies Act (Revised) of the Cayman Islands as the same may be amended from time to time; ● “completion window” are to (i) the period ending on the date that is 24 months from the closing of our initial public offering, of such earlier liquidation date as our board of directors may approve, in which we must complete an initial business combination or (ii) such other time period in which we must complete an initial business combination pursuant to an amendment to our amended and restated memorandum and articles of association.

Financial trend for Soulpower Acquisition Corp. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) was tagged only for 2025-12-31 at $5.96 million; total assets went from $100,548 (2024-12-31) to $259.13 million (2025-12-31), a change of +257613.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2025608, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Soulpower Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Soulpower Acquisition Corp. (CIK 2025608) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Soulpower Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 11 such filings (424B4, 425, S-1, S-1/A, S-1MEF) appear in its recent index, the newest dated 2026-09-03.

Current reports. Of the 14 8-K or 6-K reports in Soulpower Acquisition Corp.’s recent EDGAR index, the 4 listed here run from 2026-04-06 to 2026-09-03, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2025608 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2024-08-14. Insider trades for Soulpower Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Spartacus acquisition corp. ii forecast and analysis

This section ties “Spartacus acquisition corp. ii forecast and analysis” to Spartacus Acquisition Corp. II (ticker TMTS, TMTSU, TMTSW), SEC Central Index Key 2097364, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G dated 2026-08-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-27 by Spartacus Acquisition Corp. II (CIK 2097364) — source document:

We are a blank check company incorporated on November 4, 2025 as a Cayman Islands exempted company and formed for the purpose of effecting a Business Combination with one or more businesses or entities. We may pursue an initial Business Combination in any business or industry. To date, our efforts have been limited to (i) organizational activities, (ii) activities related to our Initial Public Offering, and (iii) searching for and consummating a Business Combination. As of the date of this Report, we have not selected any specific Business Combination target. We have generated no operating revenues to date, and we do not expect that we will generate operating revenues until we consummate our initial Business Combination.

Financial trend for Spartacus Acquisition Corp. II from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from $899,846 (2026-03-31) to $1.93 million (2026-06-30), a change of +114.3%; total assets went from $232.14 million (2026-03-31) to $234.07 million (2026-06-30), a change of +0.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2097364, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Spartacus Acquisition Corp. II did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Spartacus Acquisition Corp. II (CIK 2097364) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Spartacus Acquisition Corp. II — registration statements, prospectuses and merger proxies — are filed on EDGAR; 3 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-02-11.

Current reports. Of the 3 8-K or 6-K reports in Spartacus Acquisition Corp. II’s recent EDGAR index, the 3 listed here run from 2026-02-17 to 2026-03-31, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2097364 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2025-12-23. Insider trades for Spartacus Acquisition Corp. II appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Stevanato group s.p.a. bullish and bearish analyst opinions

This section ties “Stevanato group s.p.a. bullish and bearish analyst opinions” to Stevanato Group S.p.A. (ticker STVN), SEC Central Index Key 1849853, an EDGAR registrant classified as “Surgical & Medical Instruments & Apparatus” and organised in an unstated jurisdiction. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-09-30. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-03-04 by Stevanato Group S.p.A. (CIK 1849853) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 69 A. operating results 69 B. liquidity and capital resources 82 C. research and development, patents and licenses etc. 94 D. trend information 94 E. critical accounting estimates 94 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 95 A. DIRECTORS AND SENIOR MANAGEMENT 95 B. COMPENSATION 99 C. BOARD PRACTICES 102 D. EMPLOYEES 107 E. SHARE OWNERSHIP 108 f. disclosure of a registrant's action to recover erroneously awarded compensation 108 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 108 A. MAJOR SHAREHOLDERS 108 B. RELATED PARTY TRANSACTIONS 109 C. INTERESTS OF EXPERTS AND COUNSEL 112 ITEM 8. FINANCIAL INFORMATION 113 A. CONSOLIDATED STATEMENTS AND OTHER FINANCIAL INFORMATION 113 B. SIGNIFICANT CHANGES 113 ITEM 9.

Financial trend for Stevanato Group S.p.A. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 983,680,000 EUR (2022-12-31) to 1,186,282,000 EUR (2025-12-31), a change of +20.6%; net income (loss) went from 143,016,000 EUR (2022-12-31) to 139,831,000 EUR (2025-12-31), a change of -2.2%; total assets went from 1,659,698,000 EUR (2022-12-31) to 2,543,974,000 EUR (2025-12-31), a change of +53.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1849853, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Stevanato Group S.p.A. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Stevanato Group S.p.A. (CIK 1849853) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-03-04. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 101 8-K or 6-K reports in Stevanato Group S.p.A.’s recent EDGAR index, the 4 listed here run from 2026-08-04 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1849853 is on the EDGAR company page; the latest 20-F there is dated 2026-03-04 and the oldest filing in the recent index dates from 2021-03-22. Insider trades for Stevanato Group S.p.A. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Syntec optics holdings, inc. bullish and bearish analyst opinions

This section ties “Syntec optics holdings, inc. bullish and bearish analyst opinions” to SYNTEC OPTICS HOLDINGS, INC. (ticker OPTX, OPTXW), SEC Central Index Key 1866816, an EDGAR registrant classified as “Optical Instruments & Lenses” and organised in DE, formerly known as OmniLit Acquisition Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13D/A dated 2026-09-21. Nothing here is a recommendation to trade the security.

Financial trend for SYNTEC OPTICS HOLDINGS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $27.84 million (2022-12-31) to $28.08 million (2025-12-31), a change of +0.9%; net income (loss) went from -$434,569 (2022-12-31) to -$1.79 million (2025-12-31), a change of -312.6%; total assets went from $22.46 million (2022-12-31) to $24.31 million (2025-12-31), a change of +8.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1866816, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures SYNTEC OPTICS HOLDINGS, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SYNTEC OPTICS HOLDINGS, INC. (CIK 1866816) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2025-10-06, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 38 8-K or 6-K reports in SYNTEC OPTICS HOLDINGS, INC.’s recent EDGAR index, the 4 listed here run from 2025-10-17 to 2026-08-25, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 196 recent EDGAR filings, SYNTEC OPTICS HOLDINGS, INC. most often filed 8-K (38), 3 (20), 10-Q (15), CORRESP (12). A selection from 2026-07-29 to 2026-09-21:

The full record for CIK 1866816 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2021-07-02. Insider trades for SYNTEC OPTICS HOLDINGS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tavia acquisition corp. bullish and bearish analyst opinions

This section ties “Tavia acquisition corp. bullish and bearish analyst opinions” to Tavia Acquisition Corp. (ticker TAVI, TAVIR, TAVIU), SEC Central Index Key 2020385, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-23. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-16 by Tavia Acquisition Corp. (CIK 2020385) — source document:

Tavia Acquisition Corp. (the “Company”) is a blank check company incorporated on March 7, 2024, as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, which we refer to throughout this Annual Report as our “business combination” or “initial business combination,” with one or more businesses or entities, which we refer to throughout this Annual Report as a “target business” or “target businesses”. While we will consider opportunities in any industry, we are strategically positioned to capitalize on transformative opportunities, focusing on sectors that are pivotal to advancing sustainability and innovation. Our investment thesis prioritizes target businesses primarily in North America and Europe, with a keen interest in new energy businesses, circular economy initiatives, and innovative agricultural and food technologies.

Financial trend for Tavia Acquisition Corp. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) was tagged only for 2025-12-31 at $3.61 million; total assets went from $116.88 million (2024-12-31) to $121.12 million (2025-12-31), a change of +3.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2020385, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Tavia Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Tavia Acquisition Corp. (CIK 2020385) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-16. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Tavia Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 10 such filings (424B4, 425, S-1, S-1/A) appear in its recent index, the newest dated 2026-07-13.

Current reports. Of the 9 8-K or 6-K reports in Tavia Acquisition Corp.’s recent EDGAR index, the 4 listed here run from 2026-06-05 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2020385 is on the EDGAR company page; the latest 10-K there is dated 2026-03-16 and the oldest filing in the recent index dates from 2024-05-15. Insider trades for Tavia Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tgs asa bullish and bearish analyst opinions

This section ties “Tgs asa bullish and bearish analyst opinions” to TGS ASA (ticker none listed), SEC Central Index Key 1403840, an EDGAR registrant classified as “no SIC description” and organised in Norway, formerly known as TGS-NOPEC Geophysical Co ASA. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a D dated 2026-08-26. Nothing here is a recommendation to trade the security.

Analyst ratings, price targets and “bullish” or “bearish” calls on TGS ASA (CIK 1403840) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

What kind of filer this is matters for “Tgs asa bullish and bearish analyst opinions”: TGS ASA’s EDGAR record from 2007-06-13 to 2026-08-26 consists only of Form D notices of exempt private offerings, which means it raised money privately rather than registering shares for public trading; REGDEX filings. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it; as a company organised in Norway, its own reports would be with Oslo Børs and Finanstilsynet (www.finanstilsynet.no).

Other filings. Across its 13 recent EDGAR filings, TGS ASA most often filed D (11), REGDEX (2). A selection from 2020-01-03 to 2026-08-26:

The full record for CIK 1403840 is on the EDGAR company page and the oldest filing in the recent index dates from 2007-06-13. Insider trades for TGS ASA appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tuhura biosciences, inc. bullish and bearish analyst opinions

This section ties “Tuhura biosciences, inc. bullish and bearish analyst opinions” to TuHURA Biosciences, Inc./NV (ticker HURA), SEC Central Index Key 1498382, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in NV, formerly known as Kintara Therapeutics, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-16. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-31 by TuHURA Biosciences, Inc./NV (CIK 1498382) — source document:

We are a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. Our proprietary Immune FxTM technology platform, or IFx, is an innate immune agonist technology designed to “trick” the body’s immune system to attack tumor cells by making tumor cells look like bacteria. Our lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. In June 2025, we initiated a single randomized placebo-controlled Phase 3 registration trial of administered as an adjunctive therapy to Keytruda ® (pembrolizumab) in first line treatment for patients with advanced or metastatic Merkel cell carcinoma who are checkpoint inhibitor naïve utilizing the FDA’s accelerated approval pathway.

Financial trend for TuHURA Biosciences, Inc./NV from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $0 (2023-12-31) to $0 (2025-12-31); net income (loss) went from -$29.32 million (2023-12-31) to -$30.05 million (2025-12-31), a change of -2.5%; total assets went from $4.36 million (2023-12-31) to $27.35 million (2025-12-31), a change of +527.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1498382, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures TuHURA Biosciences, Inc./NV did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on TuHURA Biosciences, Inc./NV (CIK 1498382) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-14, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 218 8-K or 6-K reports in TuHURA Biosciences, Inc./NV’s recent EDGAR index, the 4 listed here run from 2026-09-16 to 2026-10-16, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1498382 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2010-08-17. Insider trades for TuHURA Biosciences, Inc./NV appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ucommune international ltd bullish and bearish analyst opinions

This section ties “Ucommune international ltd bullish and bearish analyst opinions” to Ucommune International Ltd (ticker UK), SEC Central Index Key 1821424, an EDGAR registrant classified as “Services-Business Services, NEC” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-08. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-03-24 by Ucommune International Ltd (CIK 1821424) — source document:

In this Item, “we,” “us,” “our company,” “our” or “Ucommune” refers to Ucommune International Ltd, a Cayman Islands company, its subsidiaries and the consolidated VIEs. A. History and Development of the Company Ucommune International Ltd has been our ultimate holding company since November 2020 after the completion of the Business Combination. Ucommune International Ltd was incorporated in the Cayman Islands on June 16, 2020 as an exempted company with limited liability. We commenced our operations in April 2015 through Ucommune Venture. In August 2018, we established Beijing U Bazaar. We underwent a series of restructuring transactions, which primarily included the following: ● In September 2018, Ucommune Group Holdings was incorporated under the laws of the Cayman Islands. ● In December 2018, Ucommune HK was incorporated under the laws of Hong Kong. ● In January 2019, Youshenghengtong Technology, formerly known as Ucommune (Beijing) Technology Co., Ltd., was incorporated in the PRC as a wholly owned subsidiary of Ucommune HK.

Financial trend for Ucommune International Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 577,810,000 CNY (2022-12-31) to 26,120,000 CNY (2025-12-31), a change of -95.5%; net income (loss) went from -291,674,000 CNY (2022-12-31) to -4,864,000 CNY (2023-12-31), a change of +98.3%; total assets went from 1,038,366,000 CNY (2022-12-31) to 202,521,000 CNY (2025-12-31), a change of -80.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1821424, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Ucommune International Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Ucommune International Ltd (CIK 1821424) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-03-24. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 62 8-K or 6-K reports in Ucommune International Ltd’s recent EDGAR index, the 4 listed here run from 2026-05-12 to 2026-10-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1821424 is on the EDGAR company page; the latest 20-F there is dated 2026-03-24 and the oldest filing in the recent index dates from 2020-08-20. Insider trades for Ucommune International Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Verde agritech ltd bullish and bearish analyst opinions

Read from its name, “Verde agritech ltd” is a a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada) entity — “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. Its accounts and exchange notices are published through that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Verde agritech ltd bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Verde agritech ltd” appears in 16 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “verde” (search terms considered: verde, agritech).

In the 16 most relevant full-text hits returned for “Verde agritech ltd”, filings range from 2024-05-07 to 2026-08-28. The filers whose documents mention it most often are CANADIAN DERIVATIVES CLEARING CORP (CIK 0000319643) (11 hits); National Bank Financial Inc. (CIK 0002028017) (3 hits); Black Maple Capital Management LP (CIK 0001588959) (2 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 123 entities whose registered name contains the word “verde”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “verde” 123, “agritech” 19. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “verde” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Vernal capital acquisition corp bullish and bearish analyst opinions

This section ties “Vernal capital acquisition corp bullish and bearish analyst opinions” to Vernal Capital Acquisition Corp. (ticker VECA, VECA-RI, VECA-UN), SEC Central Index Key 2081690, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-09-10, and this view starts from filings dated on or before 2026-05-14. Nothing here is a recommendation to trade the security.

Financial trend for Vernal Capital Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2026-04-30 to 2026-07-31: net income (loss) went from -$25,515 (2026-04-30) to $612,215 (2026-07-31), a change of +2499.4%; total assets went from $309,060 (2026-04-30) to $102.10 million (2026-07-31), a change of +32934.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2081690, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Vernal Capital Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Vernal Capital Acquisition Corp. (CIK 2081690) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Vernal Capital Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 5 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-05-07.

Other filings. Across its 28 recent EDGAR filings, Vernal Capital Acquisition Corp. most often filed 3 (6), SCHEDULE 13G (4), 8-K (3), S-1/A (3). A selection from 2026-05-13 to 2026-06-05:

The full record for CIK 2081690 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-08-21. One example from this record is the 10-Q filed 2026-06-12 (document). Insider trades for Vernal Capital Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Westrock coffee company, llc bullish and bearish analyst opinions

This section ties “Westrock coffee company, llc bullish and bearish analyst opinions” to Westrock Coffee Co (ticker WEST), SEC Central Index Key 1806347, an EDGAR registrant classified as “Beverages” and organised in DE, formerly known as Westrock Coffee Holdings, LLC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-22. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-10 by Westrock Coffee Co (CIK 1806347) — source document:

Our mission is to build and efficiently operate the preeminent integrated coffee, tea, flavors, extracts, and ingredients solutions provider to the world’s most iconic brands. We do this to provide smallholder farmers and their families in developing countries the ability to advance their quality of life and economic well-being. ​ Our platform is built upon four fundamental pillars that position us as a leading provider of value-added beverage solutions and enable us to positively impact the coffee, tea, flavors, extracts, and ingredients ecosystems from crop to cup: (i) operate a transparent supply chain, (ii) develop innovative beverage solutions tailored to our customers’ specific needs, (iii) deliver a high quality and comprehensive set of products to our customers, and (iv) leverage our scaled international presence to serve our blue-chip customer base.

Financial trend for Westrock Coffee Co from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $867.87 million (2022-12-31) to $1.19 billion (2025-12-31), a change of +37.0%; net income (loss) went from -$55.19 million (2022-12-31) to -$90.44 million (2025-12-31), a change of -63.9%; total assets went from $746.21 million (2022-12-31) to $1.18 billion (2025-12-31), a change of +57.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1806347, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Westrock Coffee Co did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Westrock Coffee Co (CIK 1806347) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-06, and the most recent 10-K annual report was filed 2026-03-10. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 37 8-K or 6-K reports in Westrock Coffee Co’s recent EDGAR index, the 4 listed here run from 2026-06-05 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1806347 is on the EDGAR company page; the latest 10-K there is dated 2026-03-10 and the oldest filing in the recent index dates from 2020-03-12. Insider trades for Westrock Coffee Co appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Whitehawk minerals corp bullish and bearish analyst opinions

This section ties “Whitehawk minerals corp bullish and bearish analyst opinions” to WhiteHawk Minerals Corp. (ticker WHK), SEC Central Index Key 1921603, an EDGAR registrant classified as “Crude Petroleum & Natural Gas” and organised in DE, formerly known as WhiteHawk Income Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 424B3 dated 2026-10-23. Nothing here is a recommendation to trade the security.

Financial trend for WhiteHawk Minerals Corp. from quarterly and annual reports (three-month periods), periods 2025-06-30 to 2026-06-30: revenue went from $21.12 million (2025-06-30) to $29.08 million (2026-06-30), a change of +37.7%; net income (loss) went from -$219,000 (2025-06-30) to -$39.20 million (2026-06-30), a change of -17801.8%; total assets was tagged only for 2026-06-30 at $518.29 million. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1921603, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures WhiteHawk Minerals Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on WhiteHawk Minerals Corp. (CIK 1921603) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 4 8-K or 6-K reports in WhiteHawk Minerals Corp.’s recent EDGAR index, the 4 listed here run from 2026-06-10 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1921603 is on the EDGAR company page and the oldest filing in the recent index dates from 2022-04-22. Insider trades for WhiteHawk Minerals Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Wintergreen acquisition corp. bullish and bearish analyst opinions

This section ties “Wintergreen acquisition corp. bullish and bearish analyst opinions” to Wintergreen Acquisition Corp. (ticker WTG, WTGUR, WTGUU), SEC Central Index Key 2053927, an EDGAR registrant classified as “Services-Computer Programming, Data Processing, Etc.” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a S-4/A dated 2026-10-21, and this view starts from filings dated on or before 2026-08-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-27 by Wintergreen Acquisition Corp. (CIK 2053927) (passage 2, continuing from the earlier excerpt) — source document:

We have generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On December 27, 2024, MACRO DREAM Holdings Limited (our “Sponsor”) acquired 1,437,500 founder shares for an aggregate purchase price of $25,000, which represents 20% of our issued and outstanding shares after our initial public offering (as defined below). As of December 31, 2025, we had not commenced any operations. For the period from April 29, 2024 (inception) through December 31, 2025, our efforts have been limited to organizational activities as well as activities related to the Initial Public Offering (as defined below).

Financial trend for Wintergreen Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from $566,442 (2025-09-30) to $369,816 (2026-06-30), a change of -34.7%; total assets went from $58.32 million (2025-09-30) to $59.51 million (2026-06-30), a change of +2.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2053927, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Wintergreen Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Wintergreen Acquisition Corp. (CIK 2053927) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-02-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Wintergreen Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 15 such filings (424B4, 425, S-1, S-1/A, S-4) appear in its recent index, the newest dated 2026-10-21.

Current reports. Of the 7 8-K or 6-K reports in Wintergreen Acquisition Corp.’s recent EDGAR index, the 3 listed here run from 2025-05-29 to 2025-07-17, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2053927 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2025-02-14. One example from this record is the 8-K filed 2026-09-28 (document). Insider trades for Wintergreen Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Wt microelectronics co., ltd. bullish and bearish analyst opinions

The legal-form ending in “Wt microelectronics co., ltd.” is the clue: “Co., Ltd.” is the English rendering used by limited companies across East Asia. A company of that kind reports in China, Taiwan, Korea or Japan, so the place to read its annual report and announcements is the home-exchange disclosure system (SSE/SZSE in mainland China, MOPS in Taiwan, DART in Korea, EDINET in Japan) — mops.twse.com.tw.

No SEC filer could be matched to “Wt microelectronics co., ltd. bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Wt microelectronics co., ltd.” appears in 9866+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “microelectronics” (search terms considered: microelectronics).

A broader EDGAR full-text search for the shorter phrase “Wt microelectronics co.” finds 9896+ filing documents; among the top 100, the filers mentioning it most are CAUSEWAY CAPITAL MANAGEMENT TRUST (CIK 0001156906) (15); AMBARELLA INC (AMBA) (CIK 0001280263) (10); SPDR INDEX SHARES FUNDS (CIK 0001168164) (8). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “Wt microelectronics co., ltd.”, filings range from 2012-08-22 to 2026-09-23. The filers whose documents mention it most often are CAUSEWAY CAPITAL MANAGEMENT TRUST (CIK 0001156906) (16 hits); AMBARELLA INC (AMBA) (CIK 0001280263) (10 hits); SPDR INDEX SHARES FUNDS (CIK 0001168164) (8 hits); Invesco Exchange-Traded Fund Trust II (CIK 0001378872) (7 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 26 entities whose registered name contains the word “microelectronics”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “microelectronics” 26. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “microelectronics” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET